| Karen A Hart, APRN | |
|
933 29th Street, Ashland, KY 41101 | |
| (606) 325-7500 | |
| (606) 326-9136 |
| Full Name | Karen A Hart |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 933 29th Street, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972890101 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SF0001X | Clinical Nurse Specialist - Family Health | 3007005 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| King's Daughters' Medical Center | Ashland, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Timothy S. Hart, Md, Psc | 6305019605 | 2 |
News Archive
Should every primary school pupil in the UK be given a hearing test and what's the most effective way of doing it? These are questions that a team of academics from Nottingham and Exeter will be tackling as part of a new study.
Bio-Matrix Scientific Group, Inc. and Its majority owned subsidiary Entest BioMedical Inc. announced today they have finalized a definitive agreement with Therinject LLC for the development of a new immuno-therapeutic cancer vaccine. Therinject LLC is engaged in the development of cancer treatments utilizing immunology based approaches.
Most flu immunization plans in the United States do not address how to vaccinate hard-to-reach populations (HTR)-undocumented immigrants, substance users, the homeless, homebound elderly, and minorities-and this potentially dangerous omission can lead masses of people to become ill during an outbreak of pandemic flu or other contagious disease, according to a new study by the New York Academy of Medicine in the current issue of the Journal of Urban Health.
An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device's inventors at the Stanford University School of Medicine.
› Verified 2 days ago
| Entity Name | Timothy S. Hart, Md, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518254747 PECOS PAC ID: 6305019605 Enrollment ID: O20111102000270 |
News Archive
Should every primary school pupil in the UK be given a hearing test and what's the most effective way of doing it? These are questions that a team of academics from Nottingham and Exeter will be tackling as part of a new study.
Bio-Matrix Scientific Group, Inc. and Its majority owned subsidiary Entest BioMedical Inc. announced today they have finalized a definitive agreement with Therinject LLC for the development of a new immuno-therapeutic cancer vaccine. Therinject LLC is engaged in the development of cancer treatments utilizing immunology based approaches.
Most flu immunization plans in the United States do not address how to vaccinate hard-to-reach populations (HTR)-undocumented immigrants, substance users, the homeless, homebound elderly, and minorities-and this potentially dangerous omission can lead masses of people to become ill during an outbreak of pandemic flu or other contagious disease, according to a new study by the New York Academy of Medicine in the current issue of the Journal of Urban Health.
An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device's inventors at the Stanford University School of Medicine.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen A Hart, APRN 933 29th St, Ashland, KY 41101-3021 Ph: (606) 325-7500 | Karen A Hart, APRN 933 29th Street, Ashland, KY 41101 Ph: (606) 325-7500 |
News Archive
Should every primary school pupil in the UK be given a hearing test and what's the most effective way of doing it? These are questions that a team of academics from Nottingham and Exeter will be tackling as part of a new study.
Bio-Matrix Scientific Group, Inc. and Its majority owned subsidiary Entest BioMedical Inc. announced today they have finalized a definitive agreement with Therinject LLC for the development of a new immuno-therapeutic cancer vaccine. Therinject LLC is engaged in the development of cancer treatments utilizing immunology based approaches.
Most flu immunization plans in the United States do not address how to vaccinate hard-to-reach populations (HTR)-undocumented immigrants, substance users, the homeless, homebound elderly, and minorities-and this potentially dangerous omission can lead masses of people to become ill during an outbreak of pandemic flu or other contagious disease, according to a new study by the New York Academy of Medicine in the current issue of the Journal of Urban Health.
An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device's inventors at the Stanford University School of Medicine.
› Verified 2 days ago
Janis L Rule, ARNP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 2550 Carter Ave, Ashland, KY 41101 Phone: 606-329-0727 Fax: 606-329-1327 | |
Paula Jean Hogsten, ARNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 432 - 16th Street, Suite B- Tri State Nephrology, Ashland, KY 41101 Phone: 606-329-9335 Fax: 606-324-6383 | |
Melodee B Thacker, APRN Clinical Nurse Specialist Medicare: May Accept Medicare Assignments Practice Location: 5900 Route Us 60 W Suite B, Ashland, KY 41102 Phone: 606-393-5586 Fax: 606-928-5547 |